Results 91 to 100 of about 3,282 (184)

Comparison of the efficacy of acupressure on P6 point, dexamethasone and ondansetron versus palonosetron monotherapy for preventing postoperative nausea and vomiting in laparoscopic surgery

, 2023
Chiong Woei Zhong, Ariffin Marzuki Mokhtar, Nik Abdullah Nik Mohammad, Mahamarowi Omar, Nurul Aifaa Mohd Azmi, Mohd Zulfakar Mazlan   +5 more
openalex   +2 more sources

5-HT₃ receptor antagonists for preventing postoperative nausea and vomiting after gynecological surgery: A systematic review and network meta-analysis. [PDF]

Int J Gynaecol Obstet
Xu H, Rong L, Yang S, Xing J, Dong H, Liu H, Chen X, Liu L.   +7 more
europepmc   +1 more source

Transdermal Granisetron Versus Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting Following Moderately Emetogenic Chemotherapy (Mec): a Multicenter, Randomized, Open-Label, Cross-Over, Active-Controlled, Phase Iv Study [PDF]

, 2014
Young Mi Seol
openalex   +1 more source

Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography. [PDF]

Medicina (Kaunas)
Shin HJ, Koo BW, Kim JN, Park JI, Na HS.
europepmc   +1 more source

Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]

BMC Pharmacol Toxicol
Wang L, Jin G, Wang W, Zhao J, Chen F, Li X, Jiang Y, Zhang Z, Li Q.   +8 more
europepmc   +1 more source

Palonosetron

Drugs in R & D, 1999
openaire   +2 more sources

The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study [PDF]

, 2016
Sergio D. Bergese, Erika Puente-Poushnejad, Maria A. Antor, Gerardo Capo, Vedat Yildiz, Alberto Uribe   +5 more
openalex   +1 more source

Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer. [PDF]

Einstein (Sao Paulo)
Rebouças CV, Alves RB, Yamada AMTD, Del Giglio A, Cruz FJSM.   +4 more
europepmc   +1 more source

Palonosetron versus other 5-HT₃receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States [PDF]

, 2011
Chris Craver, Julie Gayle, Sanjeev Balu, Deborah Buchner   +3 more
openalex   +1 more source

Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study. [PDF]

Support Care Cancer
Detlefsen SS, Andersen DS, Knudsen AØ, Nøttrup TJ, Möller S, Nyvang GB, Jørgensen TL, Herrstedt J, Ruhlmann CH.   +8 more
europepmc   +1 more source